Stay updated with breaking news from Ongoing Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Initial Data from the Ongoing Phase 2 Trial in Combination with the Antibody-Drug Conjugate Sacituzumab Govitecan Suggest a Potentially Meaningful Improvement in Overall Survival for Patients...
Keros Therapeutics, Inc. announced that it presented additional data from its two ongoing Phase 2 clinical trials of KER-050, one in patients with very low-, low-, or intermediate-risk myelodysplastic...
– Safety Profile Observed to Date as Monotherapy and in Combination with Venetoclax Suggests no Overlapping Toxicity – – Initial Results from Correlative Studies Demonstrate On-target...
Phase 1 combination dose escalation expected to support planned Phase 2 trial in microsatellite stable colorectal cancer Updated Phase 1 monotherapy data for XTX101 at the recommended Phase 2 dose...
/PRNewswire/ -- Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has granted TAR-200 Breakthrough Therapy Designation (BTD)...